Skip to main content
search
All Posts By

admin

Membership NewsMembership News Archive

LifeArc pledges £1.3 billion by 2030 to establish new medical innovations

This represents a doubling of LifeArc’s annual spend – a significant boost to the UK life sciences sector – and signals the charity’s intention to play a key role in establishing the UK as a global life sciences superpower. The charity has been noted as an early-stage translation specialist and seeks to accelerate scientific advances in order to bring preventative…
admin
November 26, 2021
HighlightsHighlights Archive

Government to publish MedTech strategy in first half of 2022

The proposal was disclosed after Labour MP Rosie Cooper asked whether the Secretary of State planned to increase funding available via the MedTech Funding Mandate. Mr Argar also revealed that the Department intends to work with industry on a range of approaches to “tackle the underlying causes of the lack of adoption” as part of the strategy. The plan will…
admin
November 26, 2021
HighlightsHighlights Archive

AstraZeneca opens The Discovery Centre in Cambridge

The move will bolster AstraZeneca’s efforts to develop cutting-edge therapeutics, such as nucleotide-based gene-editing and cell therapies, and support their focus on specialised and precision medicines. The company hopes that the unveiling marks a new wave of scientific innovation for the UK. It also puts the UK’s world-class life sciences cluster in Cambridge, which generates almost £3 billion annually to…
admin
November 26, 2021
Membership NewsMembership News ArchiveProcurement Working PartyProcurement Working Party Archive

BIVDA is pleased to announce a working partnership with IntelliCentrics UK

This partnership is a sector leading initiative, intended to simplify the process which is becoming increasingly prominent in Trusts. Working closely with NHS and Private hospitals through Intellicentrics, BIVDA will be able to support members to conduct their business in customer accounts with appropriate entry criteria relative to the job roles they perform, Credentialling is important for hospitals and patients…
admin
November 26, 2021
Membership NewsMembership News Archive

BIVDA response submitted to MHRA UKCA consultation

The consolidated BIVDA response to the MHRA consultation on the future regulation of medical devices in the United Kingdom was submitted on 25 November. This was a full response to all sections relevant to IVDs, and was based on feedback provided by members. BIVDA have also drafted a cover letter to be provided to MHRA separately, supplementing the information provided…
admin
November 26, 2021
HighlightsHighlights Archive

Health and Care Bill passes House of Commons stages

The Health and Care Bill went through its remaining stages in the House of Commons this week. Amendments were made to the Bill regarding some of the following areas: the workforce in the health service or related sectors, cosmetic procedures, virginity testing or hymenoplasty, and clauses relating to the Health Services Safety Investigations Body. Branding of e-cigarettes was also debated…
admin
November 26, 2021
AMR TaskforceAMR Taskforce ArchiveConsultations Archive

UK Health Security Agency – sepsis consultation

Closing: 29/11/2021 New Consultation: UK SMI S 12: sepsis and other systemic and disseminated infections | See here BIVDA is seeking company input members of the AMR working party to respond on behalf of the sector. Please send your comments to Ashleigh no later than Wednesday 24 November COB. Please register for a Ad-Hoc AMR consultation response meeting with Doris-Ann…
admin
November 19, 2021
Consultations ArchiveRegulatory Affairs Working PartyRegulatory Affairs Working Party Archive

Consultation on specific IVD related GMDN terms

The GMDN Agency have provided the summary information below. This is regarding a consultation on specific IVD related GMDN terms. The IVD Team at the GMDN Agency have launched a consultation regarding a proposed scaling back of antibody-specific IVD terms within the GMDN. The move would be to consolidate all infectious disease antibody-class specific terms for a particular analyte to…
admin
November 19, 2021
Consultations Archive

MHRA Consultation on the UK’s future medical device regulatory regime

The MHRA has launched the public consultation on the future medical devices regime, with survey responses requested from industry stakeholders. BIVDA’s Regulatory Affairs Working Party has a sub-group dedicated to UKCA matters and will be working on an industry response to the consultation. Members are advised to submit their own responses independently as a priority. The consultation closes at 11:45pm…
admin
November 16, 2021
Close Menu